Singapore markets closed

Xbrane Biopharma AB (7XB.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
0.0235+0.0027 (+13.50%)
As of 12:43PM CEST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-427,180
-388,172
-172,513
-188,376
-226,026
-
Depreciation & amortisation
-
-
-
12,998
6,566
7,326
Stock-based compensation
-
-
-
4,551
1,293
2,092
Change in working capital
-141,007
-119,156
-30,732
-38,415
-18,628
-
Inventory
-133,549
-56,596
-50,260
0
-
0
Other working capital
-464,630
-423,447
-254,043
-296,960
-242,262
-
Other non-cash items
-
-
-
-1,304
2,297
2,949
Net cash provided by operating activities
-463,222
-406,678
-193,918
-219,610
-238,407
-
Cash flows from investing activities
Investments in property, plant and equipment
-1,408
-16,769
-60,125
-77,350
-3,855
-
Net cash used for investing activities
-1,408
-16,769
-60,125
-77,350
-3,855
-
Net change in cash
152,523
-124,752
-105,179
52,406
80,461
-
Cash at beginning of period
118,746
193,994
295,180
243,139
164,197
-
Cash at end of period
271,270
65,402
193,994
295,180
243,139
-
Free cash flow
Operating cash flow
-463,222
-406,678
-193,918
-219,610
-238,407
-
Capital expenditure
-1,408
-16,769
-60,125
-77,350
-3,855
-
Free cash flow
-464,630
-423,447
-254,043
-296,960
-242,262
-